financetom
Business
financetom
/
Business
/
Case IH Tractor Maker Bears Sour Agriculture Market, Tariff Hits
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Case IH Tractor Maker Bears Sour Agriculture Market, Tariff Hits
Nov 7, 2025 6:22 AM

CNH Industrial N.V. ( CNH ) shares climbed premarket on Friday after the company reported third-quarter fiscal 2025 results.

CNH Industrial’s main brands include Case IH and New Holland Agriculture for the global agriculture market, and CASE Construction Equipment and New Holland Construction for the global construction market.

Details

The company reported adjusted earnings of 8 cents per share, missing the consensus of 13 cents per share.

CNH Industrial ( CNH ) reported revenue of $4.40 billion, beating analyst estimates of $3.91 billion.

Total revenue was down 5% year over year (Y/Y) in the quarter due to weak industry demand and continued channel destocking.

Due to weaker industry demand and channel inventory reductions, the company produced fewer units in 2025, which pressured segment margins.

The company reported $659 million in net cash from operations and $188 million in industrial free cash flow absorption in the quarter.

Segment Performance

Agriculture net sales fell 10% Y/Y to $2.96 billion, due to lower North American shipments and channel inventory reductions.

Meanwhile, Construction net sales rose 8% Y/Y to $739 million, led by higher shipment volumes in North America and EMEA and improved net pricing.

Financial Services revenue grew 4% Y/Y to $684 million, driven by higher yields in Brazil and positive currency effects.

Management Commentary

“While the current trade environment remains challenging for our farmers and builders, CNH continues to take decisive actions to navigate near-term headwinds. We are maintaining disciplined production levels, reducing channel inventories, investing in technology, and driving operational excellence,” CEO Gerrit Marx said in the earnings release.

Outlook

CNH Industrial ( CNH ) lowered fiscal 2025 adjusted EPS guidance to 44 cents–50 cents from 50 cents–70 cents, compared with a 59 cents analyst estimate.

CNH faces added cost pressure from expanded U.S. steel and aluminum tariffs in 2025. Mitigation efforts have only partly offset the impact, and sharing net tariff costs with customers is weighing on margins.

The guidance cut reflects incremental tariff headwinds and an unfavorable geographic sales mix.

The company sees free cash flow of Industrial Activities of $200 million-$500 million for the year.

Net sales in the Construction segment are expected to be down 3%-5% and the Agriculture segment net sales are expected to decline 11% and 13%.

Price Action: CNH shares were trading lower by 12.18% to $9.010 premarket at last check Friday.

Read Next:

Forget Bulldozers — Caterpillar CEO Says AI Data Centers Are The New Power Move

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kroger, Albertsons amend asset sale agreement with C&S Wholesale
Kroger, Albertsons amend asset sale agreement with C&S Wholesale
Apr 22, 2024
(Reuters) -Kroger ( KR ) and Albertsons Cos ( ACI ) said on Monday that they have amended their definitive agreement with C&S Wholesale Grocers for the sale of assets in connection with their proposed merger. The companies have updated their divestiture package to increase the total store count by 166 to include 579 stores that will be sold to...
Lexeo Therapeutics Signs License Deal With Cornell for Potential Friedreich Ataxia Cardiomyopathy Drug
Lexeo Therapeutics Signs License Deal With Cornell for Potential Friedreich Ataxia Cardiomyopathy Drug
Apr 22, 2024
08:47 AM EDT, 04/22/2024 (MT Newswires) -- Lexeo Therapeutics ( LXEO ) said Monday that it has signed an in-license agreement with Cornell University to expedite the development of investigational gene therapy candidate LX2006 to treat Friedreich ataxia cardiomyopathy. Under the deal, Lexeo said it has acquired certain rights, including rights to current and future data generated in an ongoing...
IDEAYA Biosciences Selects Move-Forward Expansion Dose for Mid-Stage Trial of IDE397 Monotherapy
IDEAYA Biosciences Selects Move-Forward Expansion Dose for Mid-Stage Trial of IDE397 Monotherapy
Apr 22, 2024
08:45 AM EDT, 04/22/2024 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) said Monday that it has selected a move-forward expansion dose for a mid-stage trial evaluating its IDE397 monotherapy in MTAP-deletion squamous non-small cell lung cancer, or NSCLC. Squamous NSCLC has been identified as the most sensitive tumor type of IDE397 monotherapy, the company said. There are more than...
Satellogic Commits to Backing Amazon Rainforest Monitoring Project
Satellogic Commits to Backing Amazon Rainforest Monitoring Project
Apr 22, 2024
08:49 AM EDT, 04/22/2024 (MT Newswires) -- Satellogic ( SATL ) said Monday it signed a letter of intent with O.N.E. Amazon to advance conservation goals. Financial terms of the preliminary deal were not disclosed. Satellogic ( SATL ) will use its technology to power O.N.E. Amazon's project to create what it describes as an Internet of Forests, a network...
Copyright 2023-2026 - www.financetom.com All Rights Reserved